FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Priority Review for Mercks Vericiguat

FDA is giving priority review to a Merck/Bayer NDA for vericiguat to treat some chronic heart failure patients.

Federal Register

Draft on Foreign Studies in Animal Drugs

Federal Register notice: FDA makes available a draft guidance on using data from foreign investigational studies in new animal drug applications.

Medical Devices

Respirator Decontamination Webinar

A CDRH Webinar discusses methods for decontaminating N95 masks for re-use and agency guidance on decontamination.

Human Drugs

Biologics Approvals May Be at Risk: Attorneys

Hogan Lovells attorneys say FDA authority to approve biosimilars under the BPCIA could end if the Supreme Court throws out the Affordable Care Act and...

Human Drugs

Panel Delivers Mixed Vote on Mallinckrodt Kidney Drug

An FDA advisory committee provides a mixed vote (8 to 7) in favor of approval for Mallinckrodts terlipressin and its use to treat adults with hepatore...

Human Drugs

Clinical Computer 510(k) for Fetal Monitor

FDA clears a Clinical Computer Systems 510(k) for the Obix BeCA fetal monitor.

Federal Register

Guide on Incentives for Animal Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Special Considerations, Incentives, and Programs to Support the Approval of New...

Human Drugs

FDA Finds Deficiencies in Tricida Veverimer NDA

FDA says there are deficiencies in the Tricida NDA for its veverimir to treat metabolic acidosis in patients with chronic kidney disease.

Medical Devices

CME America Updates Recalled BodyGuard Tests

FDA reports on additional flow-rate accuracy conducted by CME America on its recalled BodyGuard infusion system administration sets.

Human Drugs

FDA Approves New Epclusa Indication

FDA summarizes Epclusa label changes to cover a new Covid indication.